
A GLP-1 receptor agonist widely reported for significant weight loss and appetite suppression.
Semaglutide's fingerprint across categories
Report volume over 12 months
"Lost 40 lbs in 4 months. Nothing else ever worked like this for me."
"The food noise in my head is finally quiet. I can walk past the fridge without thinking about it."
Interesting effects reported by users
Many users report significantly decreased desire to drink alcohol. Some former heavy drinkers report completely losing interest in alcohol within weeks of starting.
“I was a bottle-of-wine-a-night person. Week 3 on Ozempic and I literally forgot to buy wine. Just didn't think about it.”
“The alcohol thing is REAL. Used to have 2-3 beers daily for 20 years. Now? Maybe one every other week, and I don't even finish it.”
“Honestly the alcohol reduction has been almost as life-changing as the weight loss. My marriage is better. My sleep is better. Everything.”
Common especially during dose titration, usually improves over time.
Slowed digestion can lead to constipation for some users.
95% of community members report using this dosing protocol 1x weekly. Individual responses vary — start low and adjust based on your experience.
Trusted vendors recommended by the community. We may receive a commission from purchases.
USA-based, 3rd party tested, COA provided
European quality standards, bulk discounts
Competitive pricing, fast US shipping
Premium quality, pharmaceutical grade
Disclaimer: DYK Peptides may receive affiliate commissions from purchases made through these links. This does not affect our editorial integrity or the recommendations we provide. Peptides are sold for research purposes only and are not intended for human consumption. Always consult with a healthcare professional before using any research compounds.
Semaglutide is a GLP-1 receptor agonist that slows gastric emptying, reduces appetite, and affects brain regions controlling food intake.